Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-12-17

Clinical Trial Update: Serum Calprotectin Level in Patients With Rheumatoid Arthritis and Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating serum calprotectin levels in patients with rheumatoid arthritis and osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: Rheumatoid Arthritis and Osteoarthritis | Phase 4 | Status: UNKNOWN